norfloxacin has been researched along with Salmonella Infections, Animal in 4 studies
Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
Salmonella Infections, Animal: Infections in animals with bacteria of the genus SALMONELLA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fleroxacin was more potent than norfloxacin." | 1.27 | Comparative activities of norfloxacin and fleroxacin in experimental infections due to Salmonella typhimurium and Escherichia coli. ( Fabrig, J; Hof, H, 1988) |
| "Norfloxacin was ineffective at 200 mg/kg per day against E." | 1.27 | In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones. ( Bower, RR; Chu, DT; Fernandes, PB; Jarvis, KP; Ramer, NR; Shipkowitz, N, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Magdy, OS | 1 |
| Moussa, IM | 1 |
| Hussein, HA | 1 |
| El-Hariri, MD | 1 |
| Ghareeb, A | 1 |
| Hemeg, HA | 1 |
| Al-Maary, KS | 1 |
| Mubarak, AS | 1 |
| Alwarhi, WK | 1 |
| Eljakee, JK | 1 |
| Kabli, SA | 1 |
| Hof, H | 1 |
| Fabrig, J | 1 |
| Nauciel, C | 1 |
| Martin, E | 1 |
| Fernandes, PB | 1 |
| Chu, DT | 1 |
| Bower, RR | 1 |
| Jarvis, KP | 1 |
| Ramer, NR | 1 |
| Shipkowitz, N | 1 |
4 other studies available for norfloxacin and Salmonella Infections, Animal
| Article | Year |
|---|---|
Genetic diversity of Salmonella enterica recovered from chickens farms and its potential transmission to human.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Chickens; Colistin; Fluoroquinolone | 2020 |
Comparative activities of norfloxacin and fleroxacin in experimental infections due to Salmonella typhimurium and Escherichia coli.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Escherichia coli Infections; Female; Fleroxacin; Mice | 1988 |
[Comparative efficacy of ampicillin, chloramphenicol, cefotaxime, ceftriaxone and pefloxacin in experimental Salmonella typhimurium infection].
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Chloramphenicol; Female; Mice; | 1987 |
In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
Topics: Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Enterobacteriaceae In | 1986 |